Doodle Drinks (DD) aims to make all-natural soft drinks that kids can enjoy. The company cites research data arguing that children aged 18 months to 18 years are drinking 26% fewer sugary drinks and consumption for 10-year olds has fallen 35%. It wants to capture this sentiment and deliver a soft drink that's a healthy choice for both parents and their kids. DD has secured distribution with the noted distributor, Bravura Foods. It has also signed a partnership with the largest independent bottler of beverages in Europe and North America, Refresco, who have over 60 manufacturing sites globally to fulfil its objective. DD will use the investment to grow its business, execute its marketing strategy and increase its product range.
days to go:
Expired
investment:
£877,830
TheVeganKind is a plant-based supermarket subscription box service that sells different vegan and plant-based products. The company has generated a revenue of £2.5m during Nov 2018-Nov 2019. TheVeganKind had shipped more than 130,000 orders alone in 2019. There are more than 4,500 different vegan and plant-based products in stock. It has been recently voted the UK's Top Online Retailer for Vegan Shopping. TheVeganKind has more than 500,000 social followers across Facebook, Twitter, and Instagram. With the proceeds, the company will allocate 60% of the funds towards marketing and branding; 20% will go towards warehouse expansion, and in increasing its inventory; 20% will go towards operating expenditure and team expansion.
days to go:
Expired
investment:
£669,188
Wellbeing Sisters (WS) is a company that offers wellbeing advice, hosts an online shop, and sells a subscription box full of toxin-free health, beauty, and nutritional products by and for women. The company first launched its subscription box in 2019 for women trying to conceive. WS witnessed a sell-out of its series of one-off boxes tailored towards conceiving, pregnancy, early motherhood, midlife and menopause in 2020. WS aims to be a contender in the UK subscription box market that is set to be worth £1 billion by 2022. The company asserts that it has organically grown its social media following consisting of over 5,000 supporters. It will use the investment to invest in technology, product development, and marketing/PR.
days to go:
Expired
investment:
£153,394
Nelson's Distillery & School (NDAS) makes and sells craft gin from its 290-litre state-of-the-art establishment. It also educates interested folks from its 28 seat Gin school in the art of making quality craft gin. Former Chef and founder, Neil Harrison, set out to create the best craft Gin and to educate others in the process. The company has produced and sold over 100,000 bottles since its founding in 2019. It aspires to become a contender in the global gin market valued at $15 billion. NDAS asserts that it is one of a few craft gin companies to win the coveted 3-star Great British Taste award, plus 6 other awards over 2 years. The company has also signed four contracts with the Hilton & Clayton hotels, three in the UK and one in Asia. NDAS will use the investment to expand its business and establish Nelson’s Gin school in all major cities.
days to go:
Expired
investment:
£317,868
Electric Assisted Vehicles Limited or EAV is a new generation vehicle design and manufacturing company providing a world-class solution. In August, the company has been revealed at the UK EV summit in Oxford. DPD is the technical partner of EAV and it has issued Letter of Intent for 50 more EAVans. With the proceeds, the company will expand into the international market, develop the product and will set its business lease plans.
days to go:
Expired
investment:
£215,130
Hoptroff TTaaS® software is a hassle-free compliance solution for financial services under MIFID II and CAT regulations. Traceable Time as a Service (TTaaS®) ensures that timestamp records of computer transactions are accurate to the microsecond, making online transactions trustworthy, reducing fraud, regulatory risk and the cost of business for Financial Services and Media. Hoptroff is building their presence in the US – the largest potential market worth $30bn. They are fundraising with the goals to invest in PoC trials for the growing pipeline of potential global customers introduced by their partners, transitioning from annual up-front fees to monthly payments with BTR and invest in launching IP Media service.
days to go:
Expired
investment:
£865,000
Imagen is a company that has developed an automated, sophisticated algorithmic technique, PredictRx, to find the right treatment for any cancer type. Imagen collects the cancer samples from a patient, grows it in its specialised growth medium, and then subjects the medium to an automated fluorescence microscopy screening to measure drug responses on live tumour cells. The company's AI-powered biobank of over 150,000 drug responses then gives the best possible cancer treatment options, allowing the company to expand in the pharmaceutical sector by satisfying its unmet demand for patient-derived cancer models. Imgen requires investment to scale its infrastructure to create the world's leading 'Biobank' of clinically relevant patient-derived cancer models whilst building the most comprehensive big data set available in cancer research.
days to go:
Expired
investment:
£1,036,436
Alphagreen is Europe's largest online marketplace for Cannabidiol (CBD) healthcare products listing over 150 brands and more than 2,500 products on its portal. It claims that it is backed by high-profile cannabis investors like Enexis, West Creek Investments, and others. It aspires to become the leader in the CBD market that is expected to be worth over £900 million in 2025 in the UK alone. Alphagreen aspires to build a trusted ecosystem for customers with Sleep, Pain and Anxiety problems, enable them to access alternative healthcare, and distribute medical cannabis from Q3 of 2021. The company has featured in Forbes, Business Insider, Prohibition Partners, The Financial Times, and The Grocer. It will use 31% of the investment for sales and marketing, 25% for team expansion, 16% for general corporate affairs, 15% for international expansion, and 13% for technology up-gradation.
days to go:
Expired
investment:
£2,039,375
Kaelo is a design company whose patented, 'Dry-cold chamber', is an open bottle host that can be integrated into premium interiors to serve drinks at the ideal temperature. The company states that its product requires no ice, water or maintenance, and uses as little power as a lightbulb. Kaelo points out that it has achieved rapid market acceptance with over 2300 unit sales to date, with almost no marketing spend. The company is now focused on high-end kitchens in the +£30,000 category. It estimates that out of the 4.5 million of these bought every year, 70% of customers would upgrade their kitchens with Kaelo's products. Kaelo currently has 125 kitchen showrooms that are selling its products in the UK with more distributors selling across Europe and the US. It will use the investment to launch the Kaelo brand for the first time, establish Kaelo in the kitchen market, and achieve the brand's goal of reaching 37,000 units by 2025.
days to go:
Expired
investment:
£845,260
trükl is a web-based, integrated and automated parcel delivery booking platform for small businesses. The company argues that on average, 5% of all UK deliveries don’t go as planned, which amounts to over 50 million dissatisfied customer experiences. trükl intends to change this and become a contender in the parcel delivery industry that is expected to double to £21 billion by 2024. The company monitors orders for issues and alerts retailers in real-time to ensure satisfied customers across the supply chain. It has successfully monitored the delivery of 4,500+ shipments since August 2020. The company also processed 330 orders earning revenue worth £1,800 on a single day in December 2020. trükl is a member of SETsquared, an award-winning business incubator. The company will use the investment to develop its integrations further, platform features and acquire and support new retailers.
days to go:
Expired
investment:
£357,477
